Monday, November 4, 2024
HomeTagsCLARITY

CLARITY

FDA converts approval process for new Alzheimer’s disease treatment to traditional approval

The US Food and Drug Administration (FDA) converted the approval process for Leqembi ( lecanemab-irmb), indicated for the treatment of adult patients with Alzheimer's...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics